Acadian Asset Management
VIR icon

Acadian Asset Management’s Vir Biotechnology VIR Stock Holding History

Acadian Asset Management’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$535K Buy
52,739
+41,934
+388% +$399K ﹤0.01% 1428
2026
Q1 		$96K Sell
10,805
-87,086
-89% -$694K ﹤0.01% 1757
2025
Q4 		$588K Buy
97,891
+3,090
+3% +$18.4K ﹤0.01% 1259
2025
Q3 		$539K Buy
+94,801
New +$485K ﹤0.01% 1199
2025
Q2 		– Sell
-52,193
Closed -$335K – 1846
2025
Q1 		$335K Buy
+52,193
New +$464K ﹤0.01% 1159
2024
Q1 		– Sell
-2,692
Closed -$27K – 1798
2023
Q4 		$27K Sell
2,692
-144,381
-98% -$1.32M ﹤0.01% 1556
2023
Q3 		$1.38M Sell
147,073
-17,410
-11% -$248K 0.01% 783
2023
Q2 		$4.03M Sell
164,483
-11,713
-7% -$294K 0.02% 507
2023
Q1 		$4.1M Buy
176,196
+67,103
+62% +$1.72M 0.02% 510
2022
Q4 		$2.76M Sell
109,093
-90,324
-45% -$2.21M 0.01% 596
2022
Q3 		$3.84M Buy
199,417
+56,168
+39% +$1.43M 0.02% 477
2022
Q2 		$3.65M Buy
143,249
+135,531
+1,756% +$3.16M 0.02% 486
2022
Q1 		$197K Buy
+7,718
New +$229K ﹤0.01% 1217
2021
Q4 		– Sell
-4,655
Closed -$200K – 1863
2021
Q3 		$200K Buy
+4,655
New +$202K ﹤0.01% 1296

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Acadian Asset Management's VIR Position: Q2 2026 in Review

Acadian Asset Management increased its Vir Biotechnology (VIR) stake by 388% in Q2 2026, buying an estimated $399K and bringing the position to 52,739 shares worth $535K. The position accounts for ﹤0.01% of the portfolio, ranked #1428.

Acadian Asset Management first reported a position in VIR in Q3 2021 and has held it in 14 quarters since. The position peaked at $4.1M in Q1 2023. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • Acadian Asset Management held 52,739 shares of Vir Biotechnology worth $535K as of Q2 2026.
  • Acadian Asset Management bought 41,934 Vir Biotechnology shares in Q2 2026, an estimated $399K.
  • Vir Biotechnology made up ﹤0.01% of Acadian Asset Management's portfolio in Q2 2026, its #1428 holding.
  • Acadian Asset Management first reported a position in Vir Biotechnology in Q3 2021 and has held it in 14 quarters since.
  • Acadian Asset Management's Vir Biotechnology position peaked at $4.1M in Q1 2023.
  • 237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.